Boston Scientific says Penumbra close will push into Q1 2027
Boston Scientific Chief Executive Officer Mike Mahoney said the company expects to close the acquisition of Penumbra in the first quarter of 2027. “The regulatory process has taken a bit of...To view the full article, register now.
Already a subscriber? Click here to view full article